Company Description
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.
The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations.
The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide.
It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates.
Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
| Country | United States |
| Founded | 1990 |
| IPO Date | Feb 6, 2020 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 867 |
| CEO | Ramy Farid |
Contact Details
Address: 1540 Broadway, 24th Floor New York, New York 10036 United States | |
| Phone | 212 295 5800 |
| Website | schrodinger.com |
Stock Details
| Ticker Symbol | SDGR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001490978 |
| CUSIP Number | 80810D103 |
| ISIN Number | US80810D1037 |
| Employer ID | 95-4284541 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ramy Farid Ph.D. | Chief Executive Officer, President and Director |
| Dr. Richard A. Friesner Ph.D. | Co-Founder, Scientific Advisory Chairman and Director |
| Dr. Geoffrey Craig Porges MBBS | Executive Vice President and Chief Financial Officer |
| Dr. Robert Lorne Abel Ph.D. | Executive Vice President, Chief Scientific Officer of Platform and Head of Modeling Research & Development |
| Dr. Karen Akinsanya Ph.D. | President of Research and Development Therapeutics |
| Dr. Margaret Han Dugan M.D. | Chief Medical Officer |
| Prof. William Goddard III | Co-Founder and Scientific Advisor |
| Kenneth Patrick Lorton | Executive Vice President, Chief Technology Officer and Chief Operating Officer of Software |
| Shane Brauner | Executive Vice President and Chief Information Officer |
| Jaren Irene Madden | Senior Vice President of Investor Relations and Corporate Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 15, 2024 | 144 | Filing |
| Sep 12, 2024 | 8-K | Current Report |
| Jul 31, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jul 31, 2024 | 10-Q | Quarterly Report |
| Jul 31, 2024 | 8-K | Current Report |
| Jun 18, 2024 | 8-K | Current Report |